latest blog entries
Loading...
Branding...
latest headlines for company on cafepharma
Seeking Alpha
Fri, 03/22/13 - 10:43 am
Seeking Alpha
Sat, 03/09/13 - 1:44 pm
Forbes
Mon, 03/04/13 - 11:55 am
tags: Affymax, Celldex, Dynavax, Keryx, Optimer, OraSure, Pharmacyclics, Questcor, Synta Pharmaceuticals, Taro
Motley Fool
Sun, 03/03/13 - 12:27 pm
tags: Affymax, Dynavax, Optimer Pharmaceuticals, Vivus, Zogenix
TheStreet.com
Tue, 02/12/13 - 1:12 pm
Seeking Alpha
Wed, 11/21/12 - 11:40 am
TheStreet.com
Mon, 11/19/12 - 3:00 pm
Motley Fool
Fri, 11/16/12 - 11:10 am
tags: advisory panels, Dynavax, FDA, hepatitis B, Heplisav, vaccines
Minyanville
Wed, 10/31/12 - 11:52 am
Seeking Alpha
Wed, 10/31/12 - 10:49 am
Motley Fool
Mon, 10/01/12 - 11:29 am
Last 30 twitter posts
-
DYNAVAX TECHNOLOGIES (DVAX) Earnings Report: DYNAVAX TECHNOLOGIES (DVAX) reported earnings today Time Not Supp... t.co/QqyrK8VCPS
Latest Health Message Board Posts
... how weak this vaccine is there are much better vaccines, one was just approved in europe, i m not sure but it should be from dynavax or similar name, this vaccine has higher response for adults and babies at birth because it contains hbcag, hbsag, and trls ...
Posted by:
studyforhope
at
2013-03-04 06:00:00
on
medhelp.org
... have read about new medicine called DV-601 but ther is no updated information , this medication on the below link: http://www.dynavax.com/hepatitis_bt.html also the clinical trailes for this medicine with no updating information at the link: http://www. ...
Posted by:
Mrt79
at
2013-02-27 15:33:59
on
medhelp.org
... released safety and immunogenicity data from its Phase 1b clinical trial of DV-601, its proprietary hepatitis B therapeutic vaccine. Dynavax said that the candidate vaccine, DV-601, is designed to induce an immune response against HBV-infected cells and ...
Posted by:
Mrt79
at
2013-02-25 06:00:00
on
medhelp.org
Any information about DV-601 (Dynavax berkely), HAP compound Bay 41-4109 ( AiCuris Germany) , HBV Core antigen vaccine (emergent europe)?
Posted by:
stef2011
at
2012-09-03 05:00:00
on
medhelp.org
... and effective, may offer an alternative therapeutic option for patients chronically infected with HBV. About Dynavax Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat ...
Posted by:
MHMD
at
2012-08-19 05:00:00
on
medhelp.org
2 Therapeutic vaccines from China - both in Phase IIb 1 Therapeutic vaccine from Dynavax 1 Therapeutic vaccine from France LB80380 - antivral.
Posted by:
new_hepb
at
2012-04-19 05:00:00
on
medhelp.org
... therapeutic vaccinations once the s-antigen is negative. Regarding new developments on the horizon, there is a therapeutic HBV vaccine by Dynavax, that could be used eg in the context above. Replicor and Myrcludex remain the most promising partial attack ...
Posted by:
studyforhope
at
2011-09-26 05:00:00
on
medhelp.org
... --finance.html) . This is completely opposite to the response received by Dynavax from FDA on HEPLISAV (HEPLISAV is an investigational adult hepatitis B vaccine) See http://investors.dynavax.com/releasedetail.cfm?ReleaseID=742656 It appeared that all odds ...
Posted by:
StephenCastlecrag
at
2011-08-10 05:00:00
on
medhelp.org
... --finance.html) . This is completely opposite to the response received by Dynavax from FDA on HEPLISAV (HEPLISAV is an investigational adult hepatitis B vaccine) See http://investors.dynavax.com/releasedetail.cfm?ReleaseID=742656 It appeared that all odds ...
Posted by:
chanthou
at
2011-03-03 06:00:00
on
medhelp.org
... approved, maybe with the exception of Fendrix in the UK by smithkline, but that is still a mild adjuvant. The heplisav development of Dynavax where a CpG adjuvant is used to intensify the immune response and that had quite large trials with over 3000 ...
Posted by:
saramo
at
2010-12-27 06:00:00
on
medhelp.org